BOTALYS
Produces rare botanicals & ingredients aimed at the food supplement, cosmetics and pharmaceutical industries.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | €6.6m | Series B | |
| Total Funding | 000k | ||
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Botalys is a pioneering company in the field of botanical ingredients and adaptogens, specifically catering to the nutraceutical industry. The company operates in the health and wellness market, focusing on producing high-quality medicinal plant extracts. Botalys serves nutraceutical companies that require pure, consistent, and potent botanical ingredients for their products.
The core business model of Botalys revolves around indoor vertical farming, a method that allows them to grow medicinal plants in a controlled, pesticide-free environment. This innovative approach ensures that the plants maintain their natural purity and consistent molecular profile, which is often compromised in traditional mass production methods. By recreating the pristine conditions of wild harvesting, Botalys can offer superior quality adaptogens—substances that help the body adapt to stress and exert a normalizing effect upon bodily processes.
Botalys generates revenue by selling these high-quality botanical ingredients to nutraceutical companies. These companies then use the ingredients to formulate dietary supplements, functional foods, and other health-related products. The demand for such pure and potent ingredients is growing, driven by increasing consumer awareness and preference for natural health solutions.
The company has also received funding from the European Horizon 2020 research and innovation program, which underscores its commitment to research and development. This financial support helps Botalys to continually innovate and improve its farming techniques and product offerings.
In summary, Botalys stands out in the nutraceutical market by providing pristine, high-quality botanical ingredients through advanced indoor vertical farming. Their focus on purity, consistency, and innovation makes them a valuable partner for nutraceutical companies aiming to offer the best to their consumers.
Keywords: botanical ingredients, adaptogens, nutraceuticals, indoor vertical farming, medicinal plants, purity, consistency, innovation, health and wellness, European Horizon 2020.